Puerto Rican Alzheimer’s Disease Initiative
Above: Our Research Team
In January of 2016, the John P. Hussman Institute for Human Genomics (HIHG) began their effort to include Puerto Rican families in their studies with the goal of better understanding the inheritance of Alzheimer’s Disease (AD).
In June of 2016, our researchers received funding from the National Institutes of Health to develop their project titled “Genomic Characterization of Alzheimer Disease Risk in the Puerto Rican Population,” led by Dr. Margaret A. Pericak-Vance, Director of the HIHG at the University of Miami Miller School of Medicine, co-investigator Dr. Gary Beecham, Director of the Division of Research Informatics in the Center for Genetic Epidemiology and Statistical Genetics at the HIHG, and Dr. Briseida E. Feliciano-Astacio, professor at the Universidad Central del Caribe School of Medicine in Puerto Rico.
In 2016, HIHG researchers made two successful trips to several cities in Puerto Rico to continue ascertainment efforts and follow up. Their next visit is scheduled to take place in March of 2017. They will be visiting the cities of Aguadilla, Arecibo, Caguas, Carolina, Cayey, Cidra, Fajardo, Guaynabo, Manatí, Mayaguez, Ponce, and San Juan.
The potential discovery of genetic contributions to AD risk and protective variants will have substantial influence on our understanding of AD and towards our goal of identifying new target treatments. This study parallels the family-based efforts in the Alzheimer’s Disease Sequencing Project (ADSP) Discovery phase and will enhance and extend current genomic efforts such as ADSP and Alzheimer’s Disease Genetics Consortium (ADGC) to a broader AD community.
For more information, or to participate in our Puerto Rico Alzheimer disease study, please contact our study coordinator:
Katrina Celis, M.D.
Clinical Research Coordinator